论文部分内容阅读
目的:本文主要分析新氟喹诺酮类抗生素治疗支原体肺炎的临床效果。方法:选取2010年10月到2012年10月之间我院接收的80例支原体肺炎患者,随机将患者分为对照组和治疗组,各40例。对照组患者给予阿奇霉素治疗,试验组患者给予新氟喹诺酮类药物治疗。最后观察两组患者治疗效果。结果:治疗组患者的总有效率为97.50%,对照组的总有效率为85.00%;可见治疗组患者的总有效率高于对照组患者,差异有统计学意义(P<0.05)。治疗组患者的住院时间和不良反应胜于对照组,差异有统计学意义(P<0.05)。结论:新氟喹诺酮类抗生素治疗支原体肺炎,疗效显著,值得临床推广。
Objective: This article mainly analyzes the clinical effect of new fluoroquinolone antibiotics in the treatment of mycoplasma pneumonia. Methods: Eighty patients with mycoplasma pneumonia admitted from October 2010 to October 2012 in our hospital were randomly divided into control group and treatment group, 40 cases in each group. Patients in the control group were treated with azithromycin and patients in the test group were treated with neofluoroquinolones. Finally observe the treatment effect of two groups of patients. Results: The total effective rate was 97.50% in the treatment group and 85.00% in the control group. The total effective rate in the treatment group was significantly higher than that in the control group (P <0.05). The hospitalization time and adverse reactions in the treatment group were better than those in the control group, with significant difference (P <0.05). Conclusion: New fluoroquinolone antibiotics in the treatment of mycoplasma pneumonia, significant effect, worthy of clinical promotion.